Publicaciones en las que colabora con Jesús Fortún Abete (41)

2022

  1. Carbapenemase-producing Enterobacterales infections in COVID-19 patients

    Infectious Diseases, Vol. 54, Núm. 1, pp. 36-45

2021

  1. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

2020

  1. Roles of the multiplex real-time PCR assay and β-D-glucan in a high-risk population for intra-abdominal candidiasis (IAC)

    Medical mycology, Vol. 58, Núm. 6, pp. 789-796

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. T2 magnetic resonance for the diagnosis of deep-seated invasive candidiasis in a liver recipient without candidemia

    Revista Iberoamericana de Micologia, Vol. 35, Núm. 3, pp. 159-161

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2016

  1. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients

    Journal of Infection, Vol. 72, Núm. 6, pp. 738-744

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

2012

  1. Outcome of HCV/HIV-coinfected liver transplant recipients: A prospective and multicenter cohort study

    American Journal of Transplantation, Vol. 12, Núm. 7, pp. 1866-1876

2008

  1. Complicaciones infecciosas en el paciente trasplantado

    Manual sobre donación y trasplante de órganos (Madrid : Arán, 2008), pp. 659-664

  2. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria

    Journal of Infection, Vol. 56, Núm. 3, pp. 185-190

  3. Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation

    AIDS

  4. Severe Sirolimus-Related Inflammatory State Anemia in an HIV+ Liver Transplant Patient With Calcineurin Inhibitor Renal Insufficiency: A Case Report

    Transplantation Proceedings, Vol. 40, Núm. 10, pp. 3810-3812

  5. Transmission of tropical and geographically restricted infections during solid-organ transplantation

    Clinical Microbiology Reviews, Vol. 21, Núm. 1, pp. 60-96

2007

  1. Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid

    International Journal of Tuberculosis and Lung Disease, Vol. 11, Núm. 7, pp. 769-774

  2. Sputum conversion among patients with pulmonary tuberculosis: Are there implications for removal of respiratory isolation?

    Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 4, pp. 794-798

  3. Trends in neurological complications of endocarditis

    Journal of Neurology, Vol. 254, Núm. 9, pp. 1253-1259

2006

  1. Candidemia in pediatric patients with congenital heart disease

    Diagnostic Microbiology and Infectious Disease, Vol. 55, Núm. 3, pp. 203-207

  2. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 4, pp. 816-821